1. Home
  2. UK vs ZVSA Comparison

UK vs ZVSA Comparison

Compare UK & ZVSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UK
  • ZVSA
  • Stock Information
  • Founded
  • UK 2015
  • ZVSA 2014
  • Country
  • UK China
  • ZVSA United States
  • Employees
  • UK N/A
  • ZVSA N/A
  • Industry
  • UK Business Services
  • ZVSA Biotechnology: Pharmaceutical Preparations
  • Sector
  • UK Consumer Discretionary
  • ZVSA Health Care
  • Exchange
  • UK Nasdaq
  • ZVSA Nasdaq
  • Market Cap
  • UK 2.3M
  • ZVSA 2.5M
  • IPO Year
  • UK N/A
  • ZVSA N/A
  • Fundamental
  • Price
  • UK $1.09
  • ZVSA $0.65
  • Analyst Decision
  • UK
  • ZVSA
  • Analyst Count
  • UK 0
  • ZVSA 0
  • Target Price
  • UK N/A
  • ZVSA N/A
  • AVG Volume (30 Days)
  • UK 48.1K
  • ZVSA 968.0K
  • Earning Date
  • UK 06-17-2025
  • ZVSA 06-17-2025
  • Dividend Yield
  • UK N/A
  • ZVSA N/A
  • EPS Growth
  • UK N/A
  • ZVSA N/A
  • EPS
  • UK N/A
  • ZVSA N/A
  • Revenue
  • UK $23,924,045.00
  • ZVSA N/A
  • Revenue This Year
  • UK N/A
  • ZVSA N/A
  • Revenue Next Year
  • UK N/A
  • ZVSA N/A
  • P/E Ratio
  • UK N/A
  • ZVSA N/A
  • Revenue Growth
  • UK N/A
  • ZVSA N/A
  • 52 Week Low
  • UK $1.00
  • ZVSA $0.47
  • 52 Week High
  • UK $2.26
  • ZVSA $6.30
  • Technical
  • Relative Strength Index (RSI)
  • UK 47.87
  • ZVSA 54.57
  • Support Level
  • UK $1.03
  • ZVSA $0.60
  • Resistance Level
  • UK $1.13
  • ZVSA $0.73
  • Average True Range (ATR)
  • UK 0.06
  • ZVSA 0.07
  • MACD
  • UK -0.00
  • ZVSA 0.02
  • Stochastic Oscillator
  • UK 50.00
  • ZVSA 64.83

About UK Ucommune International Ltd

Ucommune International Ltd is a flexible office space provider and manager based in the People's Republic of China (PRC). The company offers long-term leasing, on-demand, and short-term leasing solutions to freelancers, start-up entrepreneurs, small and medium enterprises, and corporations. Company provide fully-serviced and well-furnished office spaces on a flexible basis. The members of the Ucommune community, which includes individuals and enterprises registered on the U bazaar mobile app, can avail of these services. The company has three operating segments: Workspace membership, Marketing and branding services, and Other services. Marketing and branding services generate the majority of the company's revenue.

About ZVSA ZyVersa Therapeutics Inc.

ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary technologies to develop drugs for patients with chronic renal or inflammatory diseases with high unmet medical needs. The company has two proprietary globally licensed drug development platforms which are Cholesterol Efflux MediatorTM, VAR 200 (2-hydroxypropyl-beta-cyclodextrin) is an injectable drug in clinical development for the treatment of renal diseases. and IC 100 is a monoclonal antibody inflammasome ASC inhibitor in preclinical development for the treatment of inflammatory conditions.

Share on Social Networks: